List view / Grid view

News

Apitope raises €12 million in Series B funding

29 September 2015 | By Victoria White

The funds will enable Apitope to progress the clinical development of its innovative pipeline which includes therapies for Factor VIII intolerance in Haemophilia A patients...

BMS and Moffitt form immuno-oncology partnership

25 September 2015 | By Victoria White

Bristol-Myers Squibb and Moffitt will conduct a range of early phase clinical studies, including clinical investigations by young investigators to strengthen their development as clinical research scientists...

New collaboration to interpret human proteome information

25 September 2015 | By Victoria White

The team of researchers will comprehensively study human proteomes with the aim of turning the vast amount of molecular information into designs for new reagents, equipment, workflows, assays and software...

MISSION Therapeutics receives funding for DUB cancer programme

24 September 2015 | By Victoria White

Deubiquitylating enzymes (DUBs) are involved in multiple cellular processes, including DNA damage and cell proliferation, and the inhibition of these enzymes has considerable potential for the generation of novel drugs...